Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]

  • In development
  • GID-TA11498
  • Expected publication date: 

Documents

Documents created during the development process.

Draft guidance

Topic selection

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6407

Topic selection